New material paves the way for remote-controlled medication and electronic pills
Biomedicines are produced by living cells and are used to treat cancer and autoimmune diseases among other things. One challenge is that the medicines are very expensive to produce, something that limits global access. Now researchers from Chalmers have invented a material that uses electrical signals to capture and release biomolecules. The new and efficient method may have a major impact in the development of biomedicines and pave the way for the development of electronic pills and drug implants.
The new material is a polymer surface* which at an electrical pulse changes
Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Tuesday 14 June 2022, at which the following resolutions were made.
Adoption of the income statement and balance sheet
The AGM adopted the Board of Directors’ submitted income statement and balance sheet for the parent company and the group for the financial year 2021.
Appropriation of the company’s profit or loss
The AGM resolved, in accordance with the Board of Directors’ proposal, that no dividend shall be paid for the financial year 2021, and that the result shall be balanced in a new account.
Discharge
